| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2902901 | Chest | 2010 | 9 Pages |
Abstract
A combination of biomarkers and clinical predictors is superior to clinical predictors or biomarkers alone for predicting mortality in ALI/ARDS and may be useful for stratifying patients in clinical trials. From a pathogenesis perspective, the degree of acute inflammation and alveolar epithelial injury are highly associated with the outcome of human ALI/ARDS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lorraine B. MD, FCCP, Tatsuki PhD, D. Dean PhD, William PhD, Gordon R. MD, FCCP, B. Taylor MD, Roy G. MD, Theodore J. MD, Thomas R. MD, Michael A. MD, FCCP, the NHLBI ARDS Clinical Trials Network the NHLBI ARDS Clinical Trials Network,